February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Merck announces positive results for KEYNOTE-756
Jul 30, 2023, 06:33

Merck announces positive results for KEYNOTE-756

In a post by Paolo Tarantino on Twitter, it says, “Merck announces positive results for KEYNOTE-756: the addition of pembrolizumab to neoadjuvant chemo significantly improved pCR rate among patients with high-risk HR+/HER2- breast cancer. Follow up ongoing for EFS (co-primary endpoint).”

For the article: Click here
Source:Paolo Tarantino / Twitter